A detailed history of Dimensional Fund Advisors LP transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 24,219 shares of VOR stock, worth $21,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,219
Previous 24,219 -0.0%
Holding current value
$21,797
Previous $24,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$1.0 - $2.2 $700 - $1,540
-700 Reduced 2.81%
24,219 $24,000
Q1 2024

May 10, 2024

BUY
$1.8 - $2.85 $7,979 - $12,634
4,433 Added 21.64%
24,919 $59,000
Q4 2023

Feb 07, 2024

SELL
$1.66 - $2.63 $18,601 - $29,471
-11,206 Reduced 35.36%
20,486 $46,000
Q3 2023

Nov 09, 2023

SELL
$2.1 - $3.35 $44,299 - $70,668
-21,095 Reduced 39.96%
31,692 $67,000
Q2 2023

Aug 09, 2023

BUY
$3.09 - $5.33 $30,584 - $52,756
9,898 Added 23.08%
52,787 $163,000
Q1 2023

May 12, 2023

BUY
$4.68 - $6.96 $6,622 - $9,848
1,415 Added 3.41%
42,889 $230,000
Q4 2022

Feb 09, 2023

BUY
$3.77 - $7.43 $32,154 - $63,370
8,529 Added 25.89%
41,474 $275,000
Q3 2022

Nov 10, 2022

BUY
$3.9 - $5.52 $128,485 - $181,856
32,945 New
32,945 $131,000

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $34.3M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.